CA-TIGO
6.4.2022 16:02:05 CEST | Business Wire | Press release
Tigo Energy, Inc. , the solar industry’s leading Flex MLPE (Module Level Power Electronics) supplier, today revealed that one of the Company’s solar systems in the Netherlands consistently produces 30% more energy by using Tigo MLPE Optimizers. The drastic increase in energy production was measured on a per-module basis by the Tigo EI software using the exclusive Reclaimed Energy feature. Solar installers planning to attend Solar Solutions International 2022 in Vijfhuizen are invited to meet with Tigo representatives to discuss hardware and software solutions like those used in this installation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220406005028/en/
The 12kWp solar system was designed and installed by homeowner Hans de Git, an energy consultant at NL HDG Energie Advies. The array spans five different roof orientations on the residence in North Holland and combines Tigo TS4-A-O optimizers with a Cloud Connect Advanced (CCA) datalogger and Tigo Access Point (TAP) antennas to enable rapid shutdown, module-level visibility, and Reclaimed Energy optimization. This universal system architecture is powered by Tigo EI software and eliminates the complications of mismatches caused by varied module orientations as well as variations in module output and inverter characteristics. Over the last two years, the system has generated 5MWh of clean energy, of which 1.5MWh represented reclaimed energy provided by the Tigo TS4-A-O optimizers.
“We started using Tigo in 2012, and we have become great fans of the Tigo family of solar MLPE optimizers because they bring benefits to us as the installer and our customers,” said Mr. de Git. “When it came time to choose equipment for a new PV installation on my own house, I didn’t hesitate to choose Tigo again. Because of the specific layout of the array, I would have needed at least five MPPTs to make it work properly, which would have meant adding at least one more inverter. With the Tigo TS4 platform, I avoided the expense of additional inverters, and I can now fully exploit the double MPP tracker of my string inverter.”
“Hearing about the success of Mr. de Git is what the solar industry is all about for me,” said Jaap van Kriekingen, business development manager for Benelux at Tigo Energy. “Tigo EI software provides a clear visual readout of energy production for homeowners, allowing them to see the benefits brought by optimization over time. This level of down-to-the-hour visualization provides the peace of mind that their PV systems are performing at their very best.”
Both Jaap van Kriekingen and Mirko Bindi, Tigo VP EMEA Sales and MD Europe, respectively, will be present at the Solar Solutions International at Expo Haarlemmermeer in Vijfhuizen, the Netherlands, from April 12-14, 2022 at IBC Solar B.V. booth nr B11.1. IBC Solar, which produces tailor-made solutions ranging from small residential PV plants to major solar projects in the Benelux region, will introduce its new AeroFix G3 mounting system at the expo.
To learn more about the Tigo TS4 platform and its exclusive Reclaimed Energy feature, read the latest case study or visit www.tigoenergy.com/ts4 .
About Tigo Energy
Tigo Energy, the worldwide leader in Flex MLPE (Module Level Power Electronics), designs innovative solar power conversion and storage products that provide customers more choice and flexibility. The Tigo TS4 platform increases solar production, decreases operating costs, and enhances safety. When combined with the Tigo Energy Intelligence (EI) platform, it delivers module, system, and fleet-level insights to maximize solar performance and minimize operating costs. The Tigo EI Residential Solar Solution , a flexible solar-plus-storage solution for home installations, rounds out the Company’s portfolio of solar energy technology. Tigo was founded in Silicon Valley in 2007 to accelerate the adoption of solar energy, and its global team supports customers whose systems reliably produce gigawatt-hours of safe solar energy on seven continents. Find us online at www.tigoenergy.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005028/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom